Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,394,644 papers from all fields of science
Search
Sign In
Create Free Account
canagliflozin anhydrous
Known as:
1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973
, Anhydrous Canagliflozin
, Canagliflozin, Anhydrous
The anhydrous form of canagliflozin, a C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
canagliflozin
canagliflozin 100 MG Oral Tablet [Invokana]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
SAT-169 CANAGLIFLOZIN IS ASSOCIATED WITH INCREASED URINARY TRACT INFECTION AMONG FEMALE DIABETIC PATIENTS
M. Imam
2020
Corpus ID: 216176658
2017
2017
Syntheses of isotope-labeled SGLT2 inhibitor canagliflozin (JNJ-28431754).
R. Lin
,
D. Hoerr
,
L. Weaner
,
Rhys Salter
Journal of labelled compounds…
2017
Corpus ID: 206089504
Canagliflozin (Invokana, JNJ-28431754) is an orally bioavailable and selective SGLT2 (subtype 2 sodium-glucose transport protein…
Expand
2017
2017
High-dose vitamin D for the prevention of RTI in young children
Drug and therapeutics bulletin
2017
Corpus ID: 4787626
The effect of different doses of vitamin D for prevention of wintertime respiratory tract infections (RTI) in preschool children…
Expand
2017
2017
Experience of using ISGTL-2 in patients with DM2 and HIV infection.
M. D. García de Lucas
,
J. Olalla
European journal of internal medicine
2017
Corpus ID: 8065606
Review
2016
Review
2016
▼ Empagliflozin, diabetes and outcomes
Drug and therapeutics bulletin
2016
Corpus ID: 206924669
The prevalence of type 2 diabetes is rising, and in 2015 more than 5% of adults in the UK were affected by this condition.1,2…
Expand
2016
2016
Typ-2-Diabetes – Erstbehandlung mit Canagliflozin und Metformin
E. Ruchalla
Diabetologie und Stoffwechsel
2016
Corpus ID: 78837479
2015
2015
Effect of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, on C‐peptide kinetics
D. Polidori
,
S. Sha
,
+6 authors
A. Stirban
Clinical pharmacology in drug development
2015
Corpus ID: 32003278
Canagliflozin, a sodium glucose co‐transporter 2 inhibitor, improves indices of β‐cell function estimated based on circulating C…
Expand
2015
2015
Composition of amorphous Canagliflozin and medicinal adjuvants and preparation method thereof
张席妮
,
熊志刚
,
胡涛
,
资春鹏
2015
Corpus ID: 146398861
A composition of amorphous Canagliflozin and medicinal adjuvants and a preparation method thereof are disclosed, the composition…
Expand
2014
2014
Synthesis and Biological Activities of 6-Deoxylated Canagliflozin
Han Shu-we
2014
Corpus ID: 86982067
6-Deoxylated Canagliflozin,4-( 6-deoxy-β-D-glucopyranosyl)-2-[5-( 4-fluorophenyl) thiophen-2-yl]-1-toluene( 8),a novel SGLT2…
Expand
2013
2013
It ' s an anti-hyperglycaemic ... It ' s a diuretic ... It ' s SGLT 2 inhibition !
J. Calado
2013
Corpus ID: 1020631
133 As we sit down to write this Editorial, the last issue of the Journal of the American Society of Nephrology stands in front…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required